Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

Todd Neale

November 11, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

Todd Neale

September 13, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Conference News ESC 2023

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Michael O'Riordan

August 31, 2023

News Features

Chaos and Questions: New Public-Access Policies Put Journals in Flux

Michael O'Riordan

August 14, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News Daily News

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Michael O'Riordan

July 11, 2023

News CV Team Pro

Viet Le

L.A. McKeown

July 07, 2023

News Opinion CV Team Dispatch

July 2023 News Roundup

L.A. McKeown

July 01, 2023

News Daily News

AHA Scientific Statement Addresses Health Disparities in PAD

L.A. McKeown

June 23, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Opinion CV Team Dispatch

March 2023 News Roundup

L.A. McKeown

March 15, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Daily News

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Michael O'Riordan

January 16, 2023

Advertisement

Mortality Risk Varies Among Patients With Very High LDL Levels

Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics

October 2023 News Roundup

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

More Details on Acoramidis’ Benefit in ATTR Cardiomyopathy: ATTRibute-CM

Chaos and Questions: New Public-Access Policies Put Journals in Flux

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Two New Studies Highlight Lack of Diversity in Cardiovascular RCTs

Viet Le

July 2023 News Roundup

AHA Scientific Statement Addresses Health Disparities in PAD

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

March 2023 News Roundup

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content